Compare ILMN & GEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ILMN | GEN |
|---|---|---|
| Founded | 1998 | 1982 |
| Country | United States | United States |
| Employees | N/A | 3500 |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.9B | 16.7B |
| IPO Year | 2000 | N/A |
| Metric | ILMN | GEN |
|---|---|---|
| Price | $128.82 | $27.10 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 7 |
| Target Price | ★ $114.93 | $35.43 |
| AVG Volume (30 Days) | 1.5M | ★ 5.3M |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 1.85% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.46 | 0.91 |
| Revenue | $4,288,000,000.00 | ★ $4,473,000,000.00 |
| Revenue This Year | N/A | $26.99 |
| Revenue Next Year | $2.08 | $4.88 |
| P/E Ratio | ★ $28.91 | $29.77 |
| Revenue Growth | N/A | ★ 16.15 |
| 52 Week Low | $68.70 | $22.74 |
| 52 Week High | $153.06 | $32.22 |
| Indicator | ILMN | GEN |
|---|---|---|
| Relative Strength Index (RSI) | 66.70 | 56.22 |
| Support Level | $124.27 | $25.97 |
| Resistance Level | $129.72 | $26.82 |
| Average True Range (ATR) | 3.90 | 0.57 |
| MACD | -0.41 | 0.14 |
| Stochastic Oscillator | 77.82 | 84.73 |
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Gen is a cybersecurity pure-play that offers security, identity protection, and privacy solutions to individual consumers. The firm's cyber safety offerings, via brands such as Norton, Avast, and LifeLock, have long maintained their positions as some of the most recognizable consumer-focused security and identity-protection products.